Monitoring M-Protein, Therapeutic Antibodies, and Polyclonal Antibodies in a Multiparametric Mass Spectrometry Assay Provides Insight into Therapy Response Kinetics in Patients with MM - Pharmaceutics 2025
Publications
08/28/2023
Development of a Targeted MS Serum Assay To Quantify M‑Protein in the Presence of Therapeutic Monoclonal Antibodies - J Proteome Res. 2018
Publications
06/29/2023
MRD Monitoring by Targeted Mass Spectrometry Allows Early Relapse Detection in MM - Blood 2022
Publications
06/29/2023
Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for MRD Monitoring in MM - Clin Chem. 2021
Publications
06/29/2023
Mass Spectrometry for Identification, Monitoring, and MRD Detection of M-Proteins - Clin Chem. 2020
Publications
06/29/2023
Multiple Myeloma MRD Detection: Targeted Mass Spectrometry in Blood vs Next-Generation Sequencing in Bone Marrow - Clin Chem. 2021
Publications
06/29/2023
Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry - Blood Cancer J. 2023
ABOUT M-inSight®
Ultra sensitive, Personalized MRD testing in Blood